EUVIMEDEUVIMED entdecken
Crossref

Guidance for patient care during drug shortages

Mary Beth Nierengarten

Cancer · 2023

DOI: 10.1002/cncr.34992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Mary Beth Nierengarten. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Oncologists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, how current and ongoing drug shortages that include two of the most widely used chemotherapy agents for treating common cancers are compounding the stress for patients and oncologists. In addition, data suggest that it is reasonable for patients with advanced non–small cell lung cancer to discontinue immunotherapy after 2 years without disease progression, and the ZUMA‐7 trial shows the value of axicabtagene ciloleucel for early relapsed B‐cell lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsOncologistsHumansPatient CareLongitudinal Studies

Substanzen

Antineoplastic Agents

Zitieren

APA

Nierengarten, M. B. (2023). Guidance for patient care during drug shortages. Cancer. https://doi.org/10.1002/cncr.34992

Vancouver

Nierengarten MB. Guidance for patient care during drug shortages. Cancer. 2023. doi:10.1002/cncr.34992

BibTeX
@article{Nierengarten2023,
  author = {Nierengarten, Mary Beth},
  title = {Guidance for patient care during drug shortages},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34992}
}
Kostenlos starten →